Novamigra Tx Announces Successful Pre-IND Meeting with FDA, Paving the Way for Accelerated Clinical Development
Novamigra Tx Announces Successful Pre-IND Meeting with FDA for Migraine Prophylaxis Asset VRG-145, Paving Way for Accelerated Clinical Development BUDAPEST, HUNGARY, January 14, 2025 /EINPresswire.com/ -- Novamigra Tx, a pioneering …